MHRA: Drug Safety Update: October 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 3 October 2024) has been published and includes articles on:

• GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse.

• Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme.

• Bromocriptine: monitor blood pressure when prescribing bromocriptine for prevention or inhibition of post-partum physiological lactation.

• Letters and medicine recalls sent to healthcare professionals in September 2024

To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.